171 related articles for article (PubMed ID: 20654688)
1. Lipid phosphatase SHIP2 downregulates insulin signalling in podocytes.
Hyvönen ME; Saurus P; Wasik A; Heikkilä E; Havana M; Trokovic R; Saleem M; Holthöfer H; Lehtonen S
Mol Cell Endocrinol; 2010 Oct; 328(1-2):70-9. PubMed ID: 20654688
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of SHIP2 in CD2AP-deficient podocytes ameliorates reactive oxygen species generation but aggravates apoptosis.
Saurus P; Tolvanen TA; Lindfors S; Kuusela S; Holthöfer H; Lehtonen E; Lehtonen S
Sci Rep; 2017 Sep; 7(1):10731. PubMed ID: 28878342
[TBL] [Abstract][Full Text] [Related]
3. SH2-containing inositol 5'-phosphatase 2 selectively impairs hypothalamic insulin signalling and regulation of food intake in mice.
Ichihara Y; Wada T; Soeda Y; Ishii Y; Sasahara M; Tsuneki H; Sasaoka T
J Neuroendocrinol; 2013 Apr; 25(4):372-82. PubMed ID: 23286299
[TBL] [Abstract][Full Text] [Related]
4. The inositol phosphatase SHIP2 negatively regulates insulin/IGF-I actions implicated in neuroprotection and memory function in mouse brain.
Soeda Y; Tsuneki H; Muranaka H; Mori N; Hosoh S; Ichihara Y; Kagawa S; Wang X; Toyooka N; Takamura Y; Uwano T; Nishijo H; Wada T; Sasaoka T
Mol Endocrinol; 2010 Oct; 24(10):1965-77. PubMed ID: 20829391
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II down-regulates nephrin-Akt signaling and induces podocyte injury: roleof c-Abl.
Yang Q; Ma Y; Liu Y; Liang W; Chen X; Ren Z; Wang H; Singhal PC; Ding G
Mol Biol Cell; 2016 Jan; 27(1):197-208. PubMed ID: 26510503
[TBL] [Abstract][Full Text] [Related]
6. Molecular cloning of rat SH2-containing inositol phosphatase 2 (SHIP2) and its role in the regulation of insulin signaling.
Ishihara H; Sasaoka T; Hori H; Wada T; Hirai H; Haruta T; Langlois WJ; Kobayashi M
Biochem Biophys Res Commun; 1999 Jun; 260(1):265-72. PubMed ID: 10381377
[TBL] [Abstract][Full Text] [Related]
7. Membrane localization of Src homology 2-containing inositol 5'-phosphatase 2 via Shc association is required for the negative regulation of insulin signaling in Rat1 fibroblasts overexpressing insulin receptors.
Ishihara H; Sasaoka T; Ishiki M; Wada T; Hori H; Kagawa S; Kobayashi M
Mol Endocrinol; 2002 Oct; 16(10):2371-81. PubMed ID: 12351701
[TBL] [Abstract][Full Text] [Related]
8. Impact of transgenic overexpression of SH2-containing inositol 5'-phosphatase 2 on glucose metabolism and insulin signaling in mice.
Kagawa S; Soeda Y; Ishihara H; Oya T; Sasahara M; Yaguchi S; Oshita R; Wada T; Tsuneki H; Sasaoka T
Endocrinology; 2008 Feb; 149(2):642-50. PubMed ID: 18039790
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity.
Wada T; Sasaoka T; Funaki M; Hori H; Murakami S; Ishiki M; Haruta T; Asano T; Ogawa W; Ishihara H; Kobayashi M
Mol Cell Biol; 2001 Mar; 21(5):1633-46. PubMed ID: 11238900
[TBL] [Abstract][Full Text] [Related]
10. Discovery and functional characterization of a novel small molecule inhibitor of the intracellular phosphatase, SHIP2.
Suwa A; Yamamoto T; Sawada A; Minoura K; Hosogai N; Tahara A; Kurama T; Shimokawa T; Aramori I
Br J Pharmacol; 2009 Oct; 158(3):879-87. PubMed ID: 19694723
[TBL] [Abstract][Full Text] [Related]
11. Dual role of SRC homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells.
Sasaoka T; Kikuchi K; Wada T; Sato A; Hori H; Murakami S; Fukui K; Ishihara H; Aota R; Kimura I; Kobayashi M
Endocrinology; 2003 Sep; 144(9):4204-14. PubMed ID: 12933696
[TBL] [Abstract][Full Text] [Related]
12. Metformin increases glucose uptake and acts renoprotectively by reducing SHIP2 activity.
Polianskyte-Prause Z; Tolvanen TA; Lindfors S; Dumont V; Van M; Wang H; Dash SN; Berg M; Naams JB; Hautala LC; Nisen H; Mirtti T; Groop PH; Wähälä K; Tienari J; Lehtonen S
FASEB J; 2019 Feb; 33(2):2858-2869. PubMed ID: 30321069
[TBL] [Abstract][Full Text] [Related]
13. SH2-containing inositol phosphatase 2 negatively regulates insulin-induced glycogen synthesis in L6 myotubes.
Sasaoka T; Hori H; Wada T; Ishiki M; Haruta T; Ishihara H; Kobayashi M
Diabetologia; 2001 Oct; 44(10):1258-67. PubMed ID: 11692174
[TBL] [Abstract][Full Text] [Related]
14. The association between the SH2-containing inositol polyphosphate 5-Phosphatase 2 (SHIP2) and the adaptor protein APS has an impact on biochemical properties of both partners.
Onnockx S; De Schutter J; Blockmans M; Xie J; Jacobs C; Vanderwinden JM; Erneux C; Pirson I
J Cell Physiol; 2008 Jan; 214(1):260-72. PubMed ID: 17620296
[TBL] [Abstract][Full Text] [Related]
15. The lipid phosphatase SHIP2 controls insulin sensitivity.
Clément S; Krause U; Desmedt F; Tanti JF; Behrends J; Pesesse X; Sasaki T; Penninger J; Doherty M; Malaisse W; Dumont JE; Le Marchand-Brustel Y; Erneux C; Hue L; Schurmans S
Nature; 2001 Jan; 409(6816):92-7. PubMed ID: 11343120
[TBL] [Abstract][Full Text] [Related]
16. Impact of the liver-specific expression of SHIP2 (SH2-containing inositol 5'-phosphatase 2) on insulin signaling and glucose metabolism in mice.
Fukui K; Wada T; Kagawa S; Nagira K; Ikubo M; Ishihara H; Kobayashi M; Sasaoka T
Diabetes; 2005 Jul; 54(7):1958-67. PubMed ID: 15983195
[TBL] [Abstract][Full Text] [Related]
17. SH2-containing inositol phosphatase 2 predominantly regulates Akt2, and not Akt1, phosphorylation at the plasma membrane in response to insulin in 3T3-L1 adipocytes.
Sasaoka T; Wada T; Fukui K; Murakami S; Ishihara H; Suzuki R; Tobe K; Kadowaki T; Kobayashi M
J Biol Chem; 2004 Apr; 279(15):14835-43. PubMed ID: 14744864
[TBL] [Abstract][Full Text] [Related]
18. Endogenous SHIP2 does not localize in lipid rafts in 3T3-L1 adipocytes.
Jacobs C; Onnockx S; Vandenbroere I; Pirson I
FEBS Lett; 2004 May; 565(1-3):70-4. PubMed ID: 15135055
[TBL] [Abstract][Full Text] [Related]
19. IRTKS Promotes Insulin Signaling Transduction through Inhibiting SHIP2 Phosphatase Activity.
Wu C; Cui X; Huang L; Shang X; Wu B; Wang N; He K; Han Z
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31212584
[TBL] [Abstract][Full Text] [Related]
20. Diabetic conditions downregulate the expression of CD2AP in podocytes via PI3-K/Akt signalling.
Ha TS; Hong EJ; Han GD
Diabetes Metab Res Rev; 2015 Jan; 31(1):50-60. PubMed ID: 24846128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
